'IFCC Seoul 2022' GC booth image.

'IFCC Seoul 2022' GC booth image.

View original image


[Asia Economy Reporter Lee Gwan-joo] On the 9th, four companies of the GC Green Cross Group?GC Green Cross Medical Foundation, GC Green Cross MS, GC Cell, and GC Genome?announced their joint participation as platinum sponsors in the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC Seoul 2022).


Marking its 24th edition this year, the IFCC is the world's most prestigious conference where approximately 4,000 experts in clinical chemistry and laboratory medicine from over 100 countries gather to share the latest knowledge in the field. It will be held from the 26th to the 30th of this month at COEX in Seoul.


The four GC Green Cross Group companies will set up a GC booth under the theme "Journey to Healthy Life," offering a program that allows participants to experience a one-stop diagnostic testing service that covers everything from specimen collection and transportation to diagnosis, testing, and result delivery.


Additionally, the four companies will host an academic seminar over two days, from the 27th to the 28th, aimed at enhancing the importance and value of diagnostic testing. Seminar topics include ▲ Evolution of Laboratory Medicine after the COVID-19 Pandemic ▲ AI-based Genetic Analysis Technology ▲ Introduction of Commercialized Technologies?Application of ADPS Technology in Liquid Biopsy & Application of PCT in Biochemical Testing. Leading experts from academia and industry in diagnostic testing will attend to discuss specialized knowledge and key issues in the field.



Lee Eun-hee, Director of GC Green Cross Medical Foundation, stated, “This event is significant as major group companies, each with expertise in different stages of the diagnostic testing process, come together to create various synergies and showcase total healthcare services. We hope it will be a meaningful opportunity to exchange important issues and the latest international trends across the field of laboratory medicine.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing